![Senthil Sundaram](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Senthil Sundaram
No más puestos en curso
Perfil
Senthil Sundaram held several positions in the pharmaceutical industry, including Chief Executive Officer & Director at Terns Pharmaceuticals, Inc., Vice President & Head-Business Development at Intercept Pharmaceuticals, Inc., and CFO & Principal Accounting Officer at Nightstar Therapeutics Ltd. He also served as an Independent Director at Sio Gene Therapies, Inc. and Social Capital Suvretta Holdings Corp.
I.
Sundaram received his undergraduate degree from Brown University.
Antiguos cargos conocidos de Senthil Sundaram.
| Empresas | Cargo | Fin |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Director Ejecutivo | 03/08/2023 |
| SIO GENE THERAPIES INC. | Director/Miembro de la Junta | 05/04/2023 |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services development of therapies for retinal dystrophies | Director/Miembro de la Junta | 07/06/2019 |
| NIGHTSTAR THERAPEUTICS PLC | Director Financiero/CFO | 07/06/2019 |
| INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2017 |
Formación de Senthil Sundaram.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
39
Relaciones de 1er grado
7
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services development of therapies for retinal dystrophies | Health Services |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops gene therapies to treat neurodegenerative diseases | Health Technology |
Nightstar Therapeutics Ltd.
 Nightstar Therapeutics Ltd. BiotechnologyHealth Technology Operates as a gene therapy company that develops novel treatments for patients suffering from inherited retinal diseases | Health Technology |
Terns Pharmaceuticals, Inc.
 Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
Social Capital Suvretta Holdings Corp. I
 Social Capital Suvretta Holdings Corp. I Financial ConglomeratesFinance Operates as blank check company | Finance |
- Bolsa de valores
- Insiders
- Senthil Sundaram
